Steering clear of type 2 diabetes (T2D) has always been a smart move, since it also protects against health problems like ...

All too often, the treatment of chronic diseases in confined to a few "tips" which may not be relevant to the person ...

A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 diabetes, in particular, is an irreversible lifelong autoimmune condition. But new ...

Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s ...

By Dennis Thompson HealthDay ReporterTUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic /Wegovy and ...

Supercede Therapeutics, Inc., a startup biotech company focused on small molecule drug development, today announced preclinical efficacy data from its lead therapeutic program to treat obesity.

Discover a study that found that individuals with higher baseline IL-1β levels experienced greater improvements in liver ...